Cost-benefit relation of diet and probiotics in iatrogenic bowel irregularity (IBI).
作者信息
Claassen Eric
机构信息
Department of Virology, Erasmus Medical Center Rotterdam, Netherlands ; Athena Institute, Vrije Universiteit Amsterdam, Netherlands.
出版信息
Front Pharmacol. 2014 Feb 17;5:14. doi: 10.3389/fphar.2014.00014. eCollection 2014.
Abstract
摘要
相似文献
1
Cost-benefit relation of diet and probiotics in iatrogenic bowel irregularity (IBI).
Front Pharmacol. 2014 Feb 17;5:14. doi: 10.3389/fphar.2014.00014. eCollection 2014.
2
Which probiotic has the best effect on preventing Clostridium difficile-associated diarrhea? A systematic review and network meta-analysis.
J Dig Dis. 2020 Feb;21(2):69-80. doi: 10.1111/1751-2980.12839.
3
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
4
Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults--a meta-analysis.
J Am Acad Nurse Pract. 2011 Jun;23(6):269-74. doi: 10.1111/j.1745-7599.2011.00617.x. Epub 2011 Apr 27.
5
Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study.
Vaccine. 2014 Jan 16;32(4):458-63. doi: 10.1016/j.vaccine.2013.11.053. Epub 2013 Nov 26.
6
Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.
CMAJ. 2005 Jul 19;173(2):167-70. doi: 10.1503/cmaj.050350.
7
Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea.
Front Pharmacol. 2014 Feb 17;5:13. doi: 10.3389/fphar.2014.00013. eCollection 2014.
8
Effectiveness of probiotics in reducing the incidence of Clostridium difficile-associated diarrhea in elderly patients: a systematic review.
JBI Database System Rev Implement Rep. 2017 Jan;15(1):140-164. doi: 10.11124/JBISRIR-2016-003234.
9
Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea.
J Med Econ. 2012;15(1):53-60. doi: 10.3111/13696998.2011.629015. Epub 2011 Oct 24.
10
Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.
Int J Gen Med. 2016 Feb 22;9:27-37. doi: 10.2147/IJGM.S98280. eCollection 2016.
本文引用的文献
1
Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea.
Front Pharmacol. 2014 Feb 17;5:13. doi: 10.3389/fphar.2014.00013. eCollection 2014.
2
Probiotic and synbiotic safety in infants under two years of age.
Benef Microbes. 2014 Mar;5(1):45-60. doi: 10.3920/BM2013.0046.
3
Food-pharma convergence in medical nutrition- best of both worlds?
PLoS One. 2013 Dec 16;8(12):e82609. doi: 10.1371/journal.pone.0082609. eCollection 2013.
4
Patient needs and research priorities in the enteral nutrition market - a quantitative prioritization analysis.
Clin Nutr. 2014 Oct;33(5):793-801. doi: 10.1016/j.clnu.2013.11.002. Epub 2013 Dec 15.
5
Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study.
Vaccine. 2014 Jan 16;32(4):458-63. doi: 10.1016/j.vaccine.2013.11.053. Epub 2013 Nov 26.
6
Human milk oligosaccharide composition differs between donor milk and mother's own milk in the NICU.
J Hum Lact. 2014 Feb;30(1):54-61. doi: 10.1177/0890334413513923. Epub 2013 Nov 26.
7
[Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products].
Med Dosw Mikrobiol. 2013;65(1):47-56.
8
A probiotic trial: tipping the balance of evidence?
Lancet. 2013 Oct 12;382(9900):1228-30. doi: 10.1016/S0140-6736(13)61571-8. Epub 2013 Aug 8.
9
The development of probiotic treatment in obesity: a review.
Benef Microbes. 2014 Mar;5(1):19-28. doi: 10.3920/BM2012.0069.
10
Use of whey permeate containing in situ synthesised galacto-oligosaccharides for the growth and preservation of Lactobacillus plantarum.
J Dairy Res. 2013 Aug;80(3):374-81. doi: 10.1017/S0022029913000356.
Zotero 插件